Seeking Alpha
01 Aug 2026, 18:12 UTC · 7w ago
Verdict
Headline takes no side. We score COLL +0.80 across four claims — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Collegium's 2026 guidance projects revenue of $865–895M and adjusted EBITDA of $475–500M with a 55% margin.
So whatConcrete financial targets and high margins provide a clear valuation benchmark for investors.
More positive than 92% of claims this week
The AZSTARYS acquisition is expected to generate $60–70M in revenue by 2026 and over $50M in annual synergies within a year.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 85% of claims this week
Collegium is transitioning its business model from a pain-management roll-up to a Central Nervous System (CNS) platform.
More positive than 65% of claims this week
The company is utilizing $300M in debt and $350M in cash to fund the AZSTARYS acquisition.
So whatIncreased leverage introduces financial risk, though offset by the strategic nature of the acquisition.
More negative than 66% of claims this week
Which stocks this story touches
More positive than 87% of ticker scores this week
The company is expanding its platform via acquisition with strong 2026 revenue and EBITDA guidance.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Reuters
1d ago
−35.7%
Price is moving against the score
$22.77 vs $35.39 close before publication (Jul 31) · not market-adjusted
COLL chart →
